| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +81.6K | 24.9% | $2.09 | +$171K |
| Sells | 4 | -246K | 75.1% | $1.26 | -$311K |
| Net | -1 | -164K | -50.2% | -$140K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Preston Klassen | President & Head of R & D, Director | $384K | +$56.1K | +17.1% | Jun 25, 2025 |
| Denis Drygin | Chief Scientific Officer | $119K | Mar 1, 2022 | ||
| Crispina Calsada | Chief Financial Officer | $0 | -$55.3K | -100% | Jun 25, 2025 |
| Christopher Aker | Sr. VP & General Counsel | $0 | -$55.1K | -100% | Jun 25, 2025 |
| Stelios Papadopoulos | Director | $0 | Jun 25, 2025 | ||
| Jason Raleigh Nunn | Director | $0 | Jun 25, 2025 | ||
| Kathryn J. Collier | Director | $0 | Jun 25, 2025 | ||
| David Baltimore | Director | $0 | +$20.8K | Jun 25, 2025 | |
| William H. Rastetter | Director | $0 | Jun 25, 2025 | ||
| Joseph P. Hagan | Chief Executive Officer, Director | $0 | -$106K | -100% | Jun 25, 2025 |
| Alice Shih-hou Huang | Director | $0 | Jun 25, 2025 | ||
| Hugh Rosen | Director | $0 | Jun 25, 2025 | ||
| Pascale Witz | Director | $0 | Jun 25, 2025 | ||
| Simos Simeonidis | Director | Jun 9, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|